NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球 BCG 疫苗市場規模調查:按類型(免疫 BCG、治療 BCG)、按人口統計(兒科(0-18 歲)、成人(19-35 歲))、按使用(醫院、診所等)、區域預測(2020-2027)

Global BCG Vaccine Market Size study, by Type (Immune BCG and Therapy BCG) Demographics (Pediatrics (0-18 Years), Adults (19-35 Years)) Application (Hospitals, Clinics, Others) and Regional Forecasts 2020-2027

出版商 Bizwit Research & Consulting LLP 商品編碼 1006295
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
全球 BCG 疫苗市場規模調查:按類型(免疫 BCG、治療 BCG)、按人口統計(兒科(0-18 歲)、成人(19-35 歲))、按使用(醫院、診所等)、區域預測(2020-2027) Global BCG Vaccine Market Size study, by Type (Immune BCG and Therapy BCG) Demographics (Pediatrics (0-18 Years), Adults (19-35 Years)) Application (Hospitals, Clinics, Others) and Regional Forecasts 2020-2027
出版日期: 2021年05月03日內容資訊: 英文
簡介

2019年全球卡介苗市場規模約為2325萬美元。

在 2020 年至 2027 年的預測期內,市場預計將以超過 4.53% 的健康增長率增長。

Calmette-Guerlain bacillus (BCG) 疫苗是唯一可用於預防結核病 (TB) 的疫苗。在結核病流行率高的國家,為臨近生日的嬰兒開出單劑量的處方。但是,在結核病罕見的地區,通常只接種高危兒童,一旦發現結核病病例,就會進行篩查並直接接種。疫苗還可以使未診斷出患有結核病並且對耐藥結核病具有抗藥性的人進行免疫接種。結核病患病率的增加,尤其是在發展中國家,以及疫苗科學領域的技術進步是 BCG 疫苗市場增長的關鍵驅動因素。

此外,根據 2018 年全球結核病報告,大多數 (66%) 結核病患者是印度 (27%)、中國 (9%)、印度尼西亞 (8%)、菲律賓 (6%)、來自一個國家的人八個國家:巴基斯坦 (5%)、尼日利亞 (4%)、孟加拉國 (4%) 和南非 (3%)。此外,世界各地的生育率上升,尤其是在中國和印度,導致需求顯著增長。此外,全球對政府政策和疫苗接種服務的關注正在推動市場增長。發展中地區投資市場不發達,市場拓展潛力大。

本報告調查了全球 BCG 疫苗市場,並按類型、人口統計、使用、地區和進入市場的公司概況提供了市場概況以及趨勢。

目錄

第 1 章執行摘要

第二章全球卡介苗市場的定義和範圍

第三章全球 BCG 疫苗市場動態

  • BCG 疫苗市場影響分析(2018-2027)

第 4 章全球卡介苗市場:行業分析

  • 波特的 5 力模型
  • PEST 分析
  • 投資採用模式
  • 分析師建議和結論

按類型分列的第 5 章全球 BCG 疫苗市場

  • 市場快照
  • 按類型劃分的全球 BCG 疫苗市場:性能-潛力分析
  • 全球 BCG 疫苗市場估計和預測,按類型:2017-2027(100 萬美元)
  • BCG 疫苗市場,細分市場分析
    • 免疫 BCG
    • 治療 BCG

按人口統計的第 6 章全球 BCG 疫苗市場

  • 市場快照
  • 按人口統計的全球 BCG 疫苗市場:性能-潛力分析
  • 全球 BCG 疫苗市場估計和預測,按人口統計:2017-2027(100 萬美元)
  • BCG 疫苗市場,細分市場分析
    • 兒科(0-18 歲)
    • 成人(19-35 歲)

按應用分列的第 7 章全球 BCG 疫苗市場

  • 市場快照
  • 按應用分列的全球 BCG 疫苗市場:性能-潛力分析
  • 全球卡介苗市場估計和預測,按應用:2017-2027(100萬美元)
  • BCG 疫苗市場,細分市場分析
    • 醫院
    • 診所
    • 其他

第 8 章全球 BCG 疫苗市場,區域分析

  • 區域市場快照
  • 北美
    • 美國
    • 加拿大
  • 歐洲快照
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他
  • 亞太地區快照
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他
  • 拉丁美洲快照
    • 巴西
    • 墨西哥
  • 其他

第9章衝突信息

  • 頂級市場策略
  • 公司簡介
    • Merck & Co. Inc.
    • Sanofi Pasteur
    • Japan BCG Laboratory
    • China National Biotech Group
    • Serum Institute of India Pvt. Ltd.
    • InterVax Ltd.
    • GreenSignal Bio Pharma Limited (GSBPL)
    • Statens Serum Institute

第10章 調查流程

目錄

Global BCG Vaccine Market is valued approximately at USD 23.25 million in 2019 and is anticipated to grow with a healthy growth rate of more than 4.53% over the forecast period 2020-2027. The Bacillus Calmette-Gurin (BCG) vaccine is the only vaccine available to prevent tuberculosis (TB). In countries with a high prevalence of tuberculosis, one dosage is prescribed for babies close to the time of birth. However, in regions where tuberculosis is rare, only children at high risk are usually immunized, while confirmed cases of tuberculosis are directly screened and administered. The vaccine also immunizes people not diagnosed ith tuberculosis and are not vulnerable to drug-resistant tuberculosis. Rising prevalence of tuberculosis, especially in developing and underdeveloped countries, as well as technological advances in the field of vaccine science, are the major factors driving the growth of the BCG vaccine market. Also, as per the Global Tuberculosis Report of 2018, the majority of TB patients (66%) live in one of eight countries: India (27%), China (9%), Indonesia (8%), the Philippines (6%), Pakistan (5%), Nigeria (4%), Bangladesh (4%) or South Africa (3 percent). In addition, growing birth rates across the world, especially in China and India, are leading to substantial demand growth. Moreover, cohesive government policies and a global focus on immunization services are pushing the growth of the market upwards. Untapped investment markets in developing regions are projected to have several possibilities for market expansion.

However, side effects of BCG vaccines impede the growth of the market over the forecast period of 2020-2027.

The regional analysis of global BCG Vaccine market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia pacific is the leading/significant region across the world in terms of market share owing to the high prevalence of TB in Asian countries such as India, Pakistan, Bangladesh and others. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rapidly increasing government efforts in form of vaccination drives would create lucrative growth prospects for the BCG Vaccine market across Asia-Pacific region.

Major market player included in this report are:

Merck & Co. Inc.

Sanofi Pasteur

Japan BCG Laboratory

China National Biotech Group

Serum Institute of India Pvt. Ltd.

InterVax Ltd.

GreenSignal Bio Pharma Limited (GSBPL)

Statens Serum Institute

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Immune BCG

Therapy BCG

By Demographics:

Pediatrics (0-18 Years)

Adults (19-35 Years)

By Application:

Hospitals

Clinics

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018

Base year - 2019

Forecast period - 2020 to 2027

Target Audience of the Global BCG Vaccine Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Million)
    • 1.2.1. BCG Vaccine Market, by Region, 2018-2027 (USD Million)
    • 1.2.2. BCG Vaccine Market, by Type, 2018-2027 (USD Million)
    • 1.2.3. BCG Vaccine Market, by Demographics, 2018-2027 (USD Million)
    • 1.2.4. BCG Vaccine Market, by Application, 2018-2027 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global BCG Vaccine Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global BCG Vaccine Market Dynamics

  • 3.1. BCG Vaccine Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global BCG Vaccine Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economic
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global BCG Vaccine Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global BCG Vaccine Market by Type, Performance - Potential Analysis
  • 5.3. Global BCG Vaccine Market Estimates & Forecasts by Type 2017-2027 (USD Million)
  • 5.4. BCG Vaccine Market, Sub Segment Analysis
    • 5.4.1. Immune BCG
    • 5.4.2. Therapy BCG

Chapter 6. Global BCG Vaccine Market, by Demographics

  • 6.1. Market Snapshot
  • 6.2. Global BCG Vaccine Market by Demographics, Performance - Potential Analysis
  • 6.3. Global BCG Vaccine Market Estimates & Forecasts by Demographics 2017-2027 (USD Million)
  • 6.4. BCG Vaccine Market, Sub Segment Analysis
    • 6.4.1. Pediatrics (0-18 Years)
    • 6.4.2. Adults (19-35 Years)

Chapter 7. Global BCG Vaccine Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global BCG Vaccine Market by Application, Performance - Potential Analysis
  • 7.3. Global BCG Vaccine Market Estimates & Forecasts by Application 2017-2027 (USD Million)
  • 7.4. BCG Vaccine Market, Sub Segment Analysis
    • 7.4.1. Hospitals
    • 7.4.2. Clinics
    • 7.4.3. Others

Chapter 8. Global BCG Vaccine Market, Regional Analysis

  • 8.1. BCG Vaccine Market, Regional Market Snapshot
  • 8.2. North America BCG Vaccine Market
    • 8.2.1. U.S. BCG Vaccine Market
      • 8.2.1.1. Type breakdown estimates & forecasts, 2017-2027
      • 8.2.1.2. Demographics breakdown estimates & forecasts, 2017-2027
      • 8.2.1.3. Application breakdown estimates & forecasts, 2017-2027
    • 8.2.2. Canada BCG Vaccine Market
  • 8.3. Europe BCG Vaccine Market Snapshot
    • 8.3.1. U.K. BCG Vaccine Market
    • 8.3.2. Germany BCG Vaccine Market
    • 8.3.3. France BCG Vaccine Market
    • 8.3.4. Spain BCG Vaccine Market
    • 8.3.5. Italy BCG Vaccine Market
    • 8.3.6. Rest of Europe BCG Vaccine Market
  • 8.4. Asia-Pacific BCG Vaccine Market Snapshot
    • 8.4.1. China BCG Vaccine Market
    • 8.4.2. India BCG Vaccine Market
    • 8.4.3. Japan BCG Vaccine Market
    • 8.4.4. Australia BCG Vaccine Market
    • 8.4.5. South Korea BCG Vaccine Market
    • 8.4.6. Rest of Asia Pacific BCG Vaccine Market
  • 8.5. Latin America BCG Vaccine Market Snapshot
    • 8.5.1. Brazil BCG Vaccine Market
    • 8.5.2. Mexico BCG Vaccine Market
  • 8.6. Rest of The World BCG Vaccine Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Merck & Co. Inc.
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Sanofi Pasteur
    • 9.2.3. Japan BCG Laboratory
    • 9.2.4. China National Biotech Group
    • 9.2.5. Serum Institute of India Pvt. Ltd.
    • 9.2.6. InterVax Ltd.
    • 9.2.7. GreenSignal Bio Pharma Limited (GSBPL)
    • 9.2.8. Statens Serum Institute

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global BCG Vaccine market, report scope
  • TABLE 2. Global BCG Vaccine market estimates & forecasts by Region 2017-2027 (USD Million)
  • TABLE 3. Global BCG Vaccine market estimates & forecasts by Type 2017-2027 (USD Million)
  • TABLE 4. Global BCG Vaccine market estimates & forecasts by Demographics 2017-2027 (USD Million)
  • TABLE 5. Global BCG Vaccine market estimates & forecasts by Application 2017-2027 (USD Million)
  • TABLE 6. Global BCG Vaccine market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 7. Global BCG Vaccine market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 8. Global BCG Vaccine market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 9. Global BCG Vaccine market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 10. Global BCG Vaccine market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 11. Global BCG Vaccine market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 12. Global BCG Vaccine market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 13. Global BCG Vaccine market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 14. Global BCG Vaccine market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 15. Global BCG Vaccine market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 16. U.S. BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 17. U.S. BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 18. U.S. BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 19. Canada BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 20. Canada BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 21. Canada BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 22. UK BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 23. UK BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 24. UK BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 25. Germany BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 26. Germany BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 27. Germany BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 28. RoE BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 29. RoE BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 30. RoE BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 31. China BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 32. China BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 33. China BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 34. India BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 35. India BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 36. India BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 37. Japan BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 38. Japan BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 39. Japan BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 40. RoAPAC BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 41. RoAPAC BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 42. RoAPAC BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 43. Brazil BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 44. Brazil BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 45. Brazil BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 46. Mexico BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 47. Mexico BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 48. Mexico BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 49. RoLA BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 50. RoLA BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 51. RoLA BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 52. Row BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 53. Row BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 54. Row BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 55. List of secondary sources, used in the study of global BCG Vaccine market
  • TABLE 56. List of primary sources, used in the study of global BCG Vaccine market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global BCG Vaccine market, research methodology
  • FIG 2. Global BCG Vaccine market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global BCG Vaccine market, key trends 2019
  • FIG 5. Global BCG Vaccine market, growth prospects 2020-2027
  • FIG 6. Global BCG Vaccine market, porters 5 force model
  • FIG 7. Global BCG Vaccine market, pest analysis
  • FIG 8. Global BCG Vaccine market, value chain analysis
  • FIG 9. Global BCG Vaccine market by segment, 2017 & 2027 (USD Million)
  • FIG 10. Global BCG Vaccine market by segment, 2017 & 2027 (USD Million)
  • FIG 11. Global BCG Vaccine market by segment, 2017 & 2027 (USD Million)
  • FIG 12. Global BCG Vaccine market by segment, 2017 & 2027 (USD Million)
  • FIG 13. Global BCG Vaccine market by segment, 2017 & 2027 (USD Million)
  • FIG 14. Global BCG Vaccine market, regional snapshot 2017 & 2027
  • FIG 15. North America BCG Vaccine market 2017 & 2027 (USD Million)
  • FIG 16. Europe BCG Vaccine market 2017 & 2027 (USD Million)
  • FIG 17. Asia pacific BCG Vaccine market 2017 & 2027 (USD Million)
  • FIG 18. Latin America BCG Vaccine market 2017 & 2027 (USD Million)
  • FIG 19. Global BCG Vaccine market, company market share analysis (2019)